12 Health Care Stocks Moving In Wednesday's After-Market Session
Onconetix Inc ONCO
$0.83
▲ +5.12%
(+$0.04)
🎈 Low Float
🎢 High Beta
🗓️ Earnings Next Week
Open
$0.77
Prev Close
$0.79
Day Range
$0.75 – $0.83
52W Range
$0.67 – $229.50
Market Cap
$3.05M
Beta
2.69
EPS (TTM)
$-219.70
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2022-02-18 |
| Shares Out. | 3,950,000 |
| Website | onconetix.com/ ↗ |
| Phone | 13024977115 |
| Employees | 2 |
| Revenue | $21,457 |
| Gross Profit | -$1,655 |
| Net Income | -$4.2M |
| Total Assets | $14.8M |
| Total Liabilities | $3.1M |
| Equity | $11.7M |
About Onconetix Inc
Onconetix Inc is a commercial-stage biotechnology company focused on the research, development, and commercialization of solutions for men's health and oncology. The company owns Proclarix, an in vitro diagnostic test for prostate cancer, approved for sale in the European Union. Additionally, it is focused on marketing Proclarix in the U.S. as a lab-developed product. Onconetix operates in one segment: commercial. Geographically, the company generates maximum revenue from Switzerland and the rest from the United Kingdom.
Onconetix Inc is a publicly traded company under the ticker symbol ONCO on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
6 analysts (2024-05-01)